Home » Topics » Disease categories and therapies » Urology

Urology
RSS

InSys in-licenses novel therapy for chronic pelvic pain syndrome

Feb. 26, 2015

Shanghai Institute Materia Medica discloses new alpha1A-adrenoreceptor antagonists

Feb. 16, 2015

ViveBio signs licensing agreement with Renovar for urine-based biomarkers for kidney disease

Feb. 13, 2015

Aurinia plans pilot biomarker study of voclosporin in lupus nephritis

Feb. 11, 2015

Tenapanor achieves primary endpoint in phase IIb hyperphosphatemia trial

Feb. 4, 2015

Xiapex approved in E.U. for Peyronie's disease

Feb. 2, 2015

CF-602 shows promise for sexual dysfunction in preclinical studies

Jan. 28, 2015

FDA awards orphan drug status to Sparsentan for focal segmental glomerulosclerosis

Jan. 13, 2015

Keryx Biopharmaceuticals launches Auryxia in the U.S.

Dec. 24, 2014

Xiapex receives positive opinion by CHMP for Peyronie's disease

Dec. 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.